|
Persistent Identifier
|
perma:LIST.2LT2QM |
|
Publication Date
|
2026-07-06 |
|
Title
| Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies [* Cross-Reference *] |
|
Other Identifier
| https://doi.org/10.1038/s41746-025-01809-6
OpenAlex ID: https://openalex.org/W4412824780 |
|
Author
| Ulrike Weirauch (Fraunhofer Institute for Cell Therapy and Immunology)
Markus Kreuz (Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0000-0002-0520-8391
Colin Birkenbihl (Fraunhofer Institute for Algorithms and Scientific Computing) - ORCID: https://orcid.org/0000-0002-7212-7700
Miriam Alb (Universitätsklinikum Würzburg) - ORCID: https://orcid.org/0000-0001-6454-9906
Maria Quaranta (Luxembourg Institute of Science and Technology, Arbed (Luxembourg)) - ORCID: https://orcid.org/0000-0001-7424-0240
Laurence Calzone (Inserm, Université Paris Sciences et Lettres) - ORCID: https://orcid.org/0000-0002-7835-1148
Sophia Orozco-Ruiz (Inserm, Université Paris Sciences et Lettres)
Stefanie Binder (University Hospital Leipzig)
Luise Fischer (University Hospital Leipzig) - ORCID: https://orcid.org/0009-0006-3619-2958
Solène Clavreul (Association des Operateurs Postaux Publics Europeens) - ORCID: https://orcid.org/0000-0001-5384-8425
Morine Maguri (Association des Operateurs Postaux Publics Europeens)
Maximilian Ferle (German Research Centre for Artificial Intelligence, Fraunhofer Institute for Cell Therapy and Immunology, Center for Scalable Data Analytics and Artificial Intelligence, Leipzig University) - ORCID: https://orcid.org/0000-0002-2730-4093
Michael Rade (Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0000-0001-6247-9289
Guillaume Azarias
Jay R. Hydren (Health Care Foundation)
Jakub Jamárik (Masaryk University) - ORCID: https://orcid.org/0000-0002-8862-2001
Dániel Schwarz (Masaryk University) - ORCID: https://orcid.org/0000-0002-9017-8245
Zsolt Sebestyén (Utrecht University, University Medical Center Utrecht) - ORCID: https://orcid.org/0000-0001-6184-7676
Jürgen Kuball (Utrecht University, University Medical Center Utrecht, European Society for Blood and Marrow Transplantation) - ORCID: https://orcid.org/0000-0002-3914-7806
Georg Popp (Fraunhofer Institute for Cell Therapy and Immunology)
Chloé Antoine (University of Namur) - ORCID: https://orcid.org/0000-0001-5875-281X
Manon Knockaert (University of Namur)
Clara T. Schoeder (German Research Centre for Artificial Intelligence, Fraunhofer Institute for Cell Therapy and Immunology, Center for Scalable Data Analytics and Artificial Intelligence, Leipzig University) - ORCID: https://orcid.org/0000-0002-4664-961X
David Fandrei (University Hospital Leipzig, Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0009-0006-4014-6030
Carmen Sanges (Universitätsklinikum Würzburg) - ORCID: https://orcid.org/0009-0000-1184-387X
Vaclovas Radvilas (European Society for Blood and Marrow Transplantation)
Nico Gagelmann (Universität Hamburg, European Society for Blood and Marrow Transplantation, University Medical Center Hamburg-Eppendorf) - ORCID: https://orcid.org/0000-0002-0891-1744
Markus Rückert
Olaf Penack (Humboldt-Universität zu Berlin) - ORCID: https://orcid.org/0000-0003-4876-802X
Stephan Fricke (Fraunhofer Institute for Cell Therapy and Immunology, Klinikum Chemnitz)
Andreas Schmidt (Singleron Biotechnologies (china)) - ORCID: https://orcid.org/0000-0001-9369-3747
Carol Ward (Roche (Switzerland)) - ORCID: https://orcid.org/0000-0002-9969-959X
Carl Steinbeißer (Project Management Institute) - ORCID: https://orcid.org/0000-0003-1493-3277
Jean-Marc Van Gyseghem (University of Namur)
Anna Niarakis (Centre National de la Recherche Scientifique, Institut national de recherche en sciences et technologies du numérique, Université Toulouse III - Paul Sabatier, Deveryware (France), Kitware (United States)) - ORCID: https://orcid.org/0000-0002-9687-7426
Laurent Garderet (Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital)
Michael Hudecek (Universitätsklinikum Würzburg, Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0000-0002-2280-2202
Thomas Neumuth (German Research Centre for Artificial Intelligence, Center for Scalable Data Analytics and Artificial Intelligence, Leipzig University) - ORCID: https://orcid.org/0000-0001-6999-5024
Uwe Platzbecker (University Hospital Leipzig) - ORCID: https://orcid.org/0000-0003-1863-3239
Ulrike Koehl (German Research Centre for Artificial Intelligence, University Hospital Leipzig, Fraunhofer Institute for Cell Therapy and Immunology, Center for Scalable Data Analytics and Artificial Intelligence) - ORCID: https://orcid.org/0000-0002-8159-9160
Regina Demlová (Masaryk University) - ORCID: https://orcid.org/0000-0002-3797-4453
Andreas Kremer (Luxembourg Institute of Science and Technology, Arbed (Luxembourg)) - ORCID: https://orcid.org/0000-0003-1466-0600
Stefan Franke (Leipzig University) - ORCID: https://orcid.org/0000-0003-2101-9168
Holger Fröhlich (University of Bonn, Fraunhofer Institute for Algorithms and Scientific Computing, Bonn Aachen International Center for Information Technology) - ORCID: https://orcid.org/0000-0002-5328-1243
Maximilian Merz (Memorial Sloan Kettering Cancer Center, University Hospital Leipzig, Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0000-0002-2805-5973
Kristin Reiche (University Hospital Leipzig, Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0000-0002-4452-4872
Maximilian Ferle (German Research Centre for Artificial Intelligence, Fraunhofer Institute for Cell Therapy and Immunology, Center for Scalable Data Analytics and Artificial Intelligence, Leipzig University) - ORCID: https://orcid.org/0000-0002-2730-4093
Jean-Marc Van Gyseghem (University of Namur)
Ulrike Köhl (German Research Centre for Artificial Intelligence, University Hospital Leipzig, Fraunhofer Institute for Cell Therapy and Immunology, Center for Scalable Data Analytics and Artificial Intelligence) |
|
Point of Contact
|
Use email button above to contact.
LIST QDKM (LIST) |
|
Description
| In (immune)oncology, virtual twins (VTs) offer patient-individual decision support. Nevertheless, current VTs do not incorporate the unique properties of engineered adoptive cellular immunotherapies (eACIs). Here, we outline the minimal design specifications for VTs for engineered ACIs (eACI-VTs) to model the complex interplay between cell product and patient physiology. We motivate utilizing VTs in eACIs to provide decision support and reflect on how eACI-VTs can support the widespread use of eACIs. (2025-08-01)
***This entry has been automatically imported via OpenAlex by LIST harvest scripts. Please refer to https://doi.org/10.1038/s41746-025-01809-6 for the original and latest version of the publication*** (2026-07-01) |
|
Subject
| Chemistry; Engineering; Medicine, Health and Life Sciences; Physics |
|
Keyword
| Immune system
Computer science
Computational biology
Adoptive cell transfer
Psychology
Neuroscience
Human–computer interaction
Medicine
Biology
Immunology
T cell |
|
Topic Classification
| CAR-T cell therapy research
Biomedical and Engineering Education
Viral Infectious Diseases and Gene Expression in Insects |
|
Deposit Date
| 2025-08-01 |
|
Data Type
| Review |
|
Data Source
| npj Digital Medicine |